Respiratory health
A Westminster Hall debate on respiratory health is scheduled for Thursday 14 November 2024. The debate will be led by Jim Shannon MP.
This pack has been prepared ahead of the general debate to be held in the Commons Chamber on Thursday 2 May on World Immunisation Week.
Commons Library debate pack - World Immunisation Week (584 KB , PDF)
There will be a general debate on World Immunisation Week in the Commons Chamber on 2 May 2019.
World Immunisation Week 2019 is a global public health campaign that aims to promote the use of vaccines to protect people from disease. The theme of the 2019 campaign is ‘Protected together: Vaccines Work!’ The World Health Organization sets out its objectives:
The main goal of the campaign is to raise awareness about the critical importance of full immunization throughout lifeAs part of the 2019 campaign, WHO and partners aim to:
Demonstrate the value of vaccines for the health of children, communities and the world.
Highlight the need to build on immunization progress while addressing gaps, including through increased investment.
Show how routine immunization is the foundation for strong, resilient health systems and universal health coverage.[1]
The World Health Organization provide information about the impact and importance of immunisation, and highlights that it is estimated to avert 2-3 million deaths a year:
Immunization is a proven tool for controlling and eliminating life-threatening infectious diseases and is estimated to avert between 2 and 3 million deaths each year. It is one of the most cost-effective health investments, with proven strategies that make it accessible to even the most hard-to-reach and vulnerable populations.[2]
General information on vaccination is provided by the following sources:
[1] WHO, World Immunisation Week 2019
[2] WHO, Immunisation [accessed 1 May 2019]
Commons Library debate pack - World Immunisation Week (584 KB , PDF)
A Westminster Hall debate on respiratory health is scheduled for Thursday 14 November 2024. The debate will be led by Jim Shannon MP.
This briefing focuses on two disease-modifying dementia drugs that are currently being appraised by the National Institute for Health and Care Excellence (NICE): lecanemab and donanemab
Information about long covid, including guidance and services for long covid patients, statistics and the impact of long covid on healthcare, employment and education.